Becton, Dickinson and Company Investor Relations Material
Latest events
Q2 2024
Becton, Dickinson and Company
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Becton, Dickinson and Company
Access all reports
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's principal businesses are based upon its expertise in the areas of vascular access devices (VADs), hemostasis systems and technologies, bioscience research tools for cell culture reagents and assays, transfusion technologies through a majority ownership interest in C.R. Bard Incorporated; Point-of-care testing instruments covering blood collection with red cell alloimmunization detection capability; transcutaneous immunoglobulin (Ig) replacement therapy; nutritionals.
Key slides for Becton, Dickinson and Company
Q4 2023
Becton, Dickinson and Company
J.P. Morgan 42nd Annual Healthcare Conference 2024
Becton, Dickinson and Company
Latest articles
Dick Smith: The Orchestrator of General Cinema's Expansion
Explore the genius of Dick Smith in revolutionizing General Cinema, as highlighted in “The Outsiders”.
8 May 2024
Alex Karp: The Unconventional Tech Visionary
Explore how Alex Karp's unique blend of ethical leadership and personal well-being shapes his role as CEO of Palantir Technologies.
8 May 2024
From Timber to Luxury: The Story of François-Henri Pinault and Kering
Dive into the story of François-Henri Pinault, from his rise in the family timber business to leading Kering into a global luxury powerhouse.
7 May 2024
Ticker symbol
Country
🇺🇸 United States